Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Top Cited Papers
- 1 December 2005
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (34), 8688-8696
- https://doi.org/10.1200/jco.2005.02.1329
Abstract
Purpose We assessed the impact of tumor regression grading (TRG) and its value in correlation to established prognostic factors in a cohort of rectal carcinoma patients treated by preoperative chemoradiotherapy (CRT). Patients and Methods TRG was evaluated on surgical specimens of 385 patients treated within the preoperative CRT arm of the CAO/ARO/AIO-94 trial: 50.4 Gy was delivered, fluorouracil was given in the first and fifth week, and surgery was performed 6 weeks thereafter. TRG was determined by the amount of viable tumor versus fibrosis, ranging from TRG 4 when no viable tumor cells were detected, to TRG 0 when fibrosis was completely absent. TRG 3 was defined as regression more than 50% with fibrosis outgrowing the tumor mass, TRG 2 was defined as regression less than 50%, and TRG 1 was defined basically as a morphologically unaltered tumor mass. We performed an initially unplanned, hypothesis-generating analysis with respect to the prognostic value of this TRG system. Results TRG 4, 3, 2, 1, 0 was found in 10.4%, 52.2%, 13.8%, 15.3%, and 8.3% of the resected specimens, respectively. Five-year disease-free survival (DFS) after CRT and curative resection was 86% for TRG 4, 75% for grouped TRG 2 + 3, and 63% for grouped TRG 0 + 1 (P = .006). On multivariate analysis, the pathologic T category and the nodal status after CRT were the most important independent prognostic factors for DFS. Conclusion In this exploratory analysis, complete (TRG 4) and intermediate pathologic response (TRG 2 + 3) suggested improved DFS after preoperative CRT. TRG assessment should be implemented in pathologic evaluation and prospectively validated in further studies.Keywords
This publication has 33 references indexed in Scilit:
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerThe New England Journal of Medicine, 2004
- Patterns of Morphologic Alteration in Residual Rectal Carcinoma Following Preoperative Chemoradiation and Their Association With Long-term OutcomeThe American Journal of Surgical Pathology, 2004
- Quantification of Histologic Regression of Rectal Cancer After IrradiationDiseases of the Colon & Rectum, 2002
- T-Level Downstaging and Complete Pathologic Response After Preoperative Chemoradiation for Advanced Rectal Cancer Result in Decreased Recurrence and Improved Disease-Free SurvivalDiseases of the Colon & Rectum, 2002
- Preoperative staging of rectal cancerInternational Journal of Colorectal Disease, 2000
- Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experienceInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancerBritish Journal of Surgery, 1997
- Pathological features of rectal cancer after preoperative radiochemotherapyInternational Journal of Colorectal Disease, 1997
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaThe New England Journal of Medicine, 1985